chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: COVID19
Symptoms: Skin discolouration
Clinical narrative: a little discoloration of the skin; This spontaneous case was reported by a consumer and describes the occurrence of SKIN DISCOLOURATION (a little discoloration of the skin ) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In May 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SKIN DISCOLOURATION (a little discoloration of the skin ). At the time of the report, SKIN DISCOLOURATION (a little discoloration of the skin ) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  The patient stated that the discoloration was not located where the vaccine was given. The patient described the discoloration as chalk white circular skin blotches the size of a pencil eraser head and did not match his body skin color.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Arthralgia, Myalgia
Clinical narrative: Can joint aches resurface 2 weeks post 2nd shot?; Can muscle aches resurface 2 weeks post 2nd shot?; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ARTHRALGIA (Can joint aches resurface 2 weeks post 2nd shot?) and MYALGIA (Can muscle aches resurface 2 weeks post 2nd shot?) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ARTHRALGIA (Can joint aches resurface 2 weeks post 2nd shot?) and MYALGIA (Can muscle aches resurface 2 weeks post 2nd shot?). At the time of the report, ARTHRALGIA (Can joint aches resurface 2 weeks post 2nd shot?) and MYALGIA (Can muscle aches resurface 2 weeks post 2nd shot?) outcome was unknown.            The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was not applicabe  No Relevant concomitant medications was reported.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia
Clinical narrative: starting to lose range of motion; I still have soreness in my arm; This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (starting to lose range of motion) and MYALGIA (I still have soreness in my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MOBILITY DECREASED (starting to lose range of motion) and MYALGIA (I still have soreness in my arm). At the time of the report, MOBILITY DECREASED (starting to lose range of motion) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information were not reported. Treatment information were not reported.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: fever of 102; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever of 102) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (fever of 102). At the time of the report, PYREXIA (fever of 102) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 (High) Fever.         No concomitant medication information given. No treatment information provided.
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Rash, Skin burning sensation
Clinical narrative: Burning skin; Red splotches; Red splotches; This spontaneous case was reported by a nurse and describes the occurrence of SKIN BURNING SENSATION (Burning skin), RASH (Red splotches) and ERYTHEMA (Red splotches) in a 72-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 29-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced SKIN BURNING SENSATION (Burning skin), RASH (Red splotches) and ERYTHEMA (Red splotches). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL A) for Burning skin and Patchy rash, at a dose of UNK dosage form. On 05-Jun-2021, SKIN BURNING SENSATION (Burning skin), RASH (Red splotches) and ERYTHEMA (Red splotches) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided.    This case was linked to MOD-2021-216184 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site swelling
Clinical narrative: Swollen at the vaccination site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (Swollen at the vaccination site) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE SWELLING (Swollen at the vaccination site). At the time of the report, VACCINATION SITE SWELLING (Swollen at the vaccination site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) and mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Head discomfort, Insomnia, Limb discomfort, Myalgia, Peripheral swelling
Clinical narrative: Some pressure on head; Left arm was extremely swollen; Could not even stretch out arm; Uncomfortable to sleep; Very sore arm/ Pain in left arm pit; This spontaneous case was reported by a consumer and describes the occurrence of HEAD DISCOMFORT (Some pressure on head), MYALGIA (Very sore arm/ Pain in left arm pit), PERIPHERAL SWELLING (Left arm was extremely swollen), LIMB DISCOMFORT (Could not even stretch out arm) and INSOMNIA (Uncomfortable to sleep) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 28-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEAD DISCOMFORT (Some pressure on head), MYALGIA (Very sore arm/ Pain in left arm pit), PERIPHERAL SWELLING (Left arm was extremely swollen), LIMB DISCOMFORT (Could not even stretch out arm) and INSOMNIA (Uncomfortable to sleep). At the time of the report, HEAD DISCOMFORT (Some pressure on head), PERIPHERAL SWELLING (Left arm was extremely swollen), LIMB DISCOMFORT (Could not even stretch out arm) and INSOMNIA (Uncomfortable to sleep) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Insomnia
Clinical narrative: Very fatigued; Insomnia; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Very fatigued) and INSOMNIA (Insomnia) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced FATIGUE (Very fatigued) and INSOMNIA (Insomnia). At the time of the report, FATIGUE (Very fatigued) and INSOMNIA (Insomnia) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication were provided. No treatment details were provided.
Sex: U
Vaccine: COVID19
Symptoms: Cardiac disorder
Clinical narrative: heart problems; This spontaneous case was reported by a patient and describes the occurrence of CARDIAC DISORDER (heart problems) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CARDIAC DISORDER (heart problems). At the time of the report, CARDIAC DISORDER (heart problems) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Concomitant medications were provided No Treatment information provided
Age: 33.0
Sex: F
Vaccine: COVID19
Symptoms: Dysmenorrhoea, Intermenstrual bleeding, Vaccination site pain
Clinical narrative: menstrual spotting on 06May2021 and still happening; like heavy menstrual cramps; only site pain like soreness; This spontaneous case was reported by a consumer and describes the occurrence of INTERMENSTRUAL BLEEDING (menstrual spotting on 06May2021 and still happening), DYSMENORRHOEA (like heavy menstrual cramps) and VACCINATION SITE PAIN (only site pain like soreness) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036B21A and 031B21A) for COVID-19 vaccination.     Concurrent medical conditions included Pollen allergy, Seasonal allergy and Penicillin allergy. Concomitant products included ESCITALOPRAM for Antidepressant drug level.   On 06-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 06-Apr-2021, the patient experienced VACCINATION SITE PAIN (only site pain like soreness). On 05-May-2021, the patient experienced INTERMENSTRUAL BLEEDING (menstrual spotting on 06May2021 and still happening) and DYSMENORRHOEA (like heavy menstrual cramps). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, INTERMENSTRUAL BLEEDING (menstrual spotting on 06May2021 and still happening), DYSMENORRHOEA (like heavy menstrual cramps) and VACCINATION SITE PAIN (only site pain like soreness) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication with birth control pill was reported by the patient . Treatment with Ibuprofen was reported by the reporter.
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: fever; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (fever) and FATIGUE (fatigue) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001C21A and 042B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 16-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 21-May-2021, the patient experienced PYREXIA (fever) and FATIGUE (fatigue). On 21-May-2021, PYREXIA (fever) and FATIGUE (fatigue) had resolved.            No concomitant medication use was provided by the reporter.  No treatment of events was reported.  Action taken with mRNA-1273 in response to the drug was not applicable.
Sex: U
Vaccine: COVID19
Symptoms: Chills, Myalgia, Pyrexia
Clinical narrative: Chills; Body hurts; Running fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of CHILLS (Chills), MYALGIA (Body hurts) and PYREXIA (Running fever) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (Chills), MYALGIA (Body hurts) and PYREXIA (Running fever). At the time of the report, CHILLS (Chills), MYALGIA (Body hurts) and PYREXIA (Running fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported.  Treatment medication was not provided.
Sex: M
Vaccine: COVID19
Symptoms: Ageusia, Anosmia, Dyspnoea, Nasopharyngitis, Vaccination complication
Clinical narrative: He has been sick for a week; Bad cold; lost his sense of smell; lost his sense of taste; had trouble breathing one night; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (He has been sick for a week), NASOPHARYNGITIS (Bad cold), ANOSMIA (lost his sense of smell), AGEUSIA (lost his sense of taste) and DYSPNOEA (had trouble breathing one night) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 03-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (He has been sick for a week), NASOPHARYNGITIS (Bad cold), ANOSMIA (lost his sense of smell), AGEUSIA (lost his sense of taste) and DYSPNOEA (had trouble breathing one night). At the time of the report, VACCINATION COMPLICATION (He has been sick for a week), NASOPHARYNGITIS (Bad cold), ANOSMIA (lost his sense of smell), AGEUSIA (lost his sense of taste) and DYSPNOEA (had trouble breathing one night) outcome was unknown.            Action taken with mRNA-1273 in response to the event was not applicable.  Treatment information was not provided. Concomitant product use was not provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: Sore right arm briefly; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE PAIN (Sore right arm briefly) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hyperlipidaemia and GERD. Concomitant products included PANTOPRAZOLE for GERD, ATORVASTATIN for Hyperlipidemia, GABAPENTIN, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), LAMOTRIGINE, CITALOPRAM and LUBIPROSTONE for an unknown indication.    On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (Sore right arm briefly). At the time of the report, VACCINATION SITE PAIN (Sore right arm briefly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided by the reporter.  Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.   Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain
Clinical narrative: abdominal cramps that doubled after every 10 mins , the abdominal pain lasted for two days; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (abdominal cramps that doubled after every 10 mins , the abdominal pain lasted for two days) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included Advil for an unknown indication.    On 17-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 17-May-2021, the patient experienced ABDOMINAL PAIN (abdominal cramps that doubled after every 10 mins , the abdominal pain lasted for two days).        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 23.0
Sex: M
Vaccine: COVID19
Symptoms: Fatigue, Feeling abnormal, Somnolence
Clinical narrative: Feeling Heavy; Feeling very drowsy; Experiencing tiredness; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Feeling Heavy), SOMNOLENCE (Feeling very drowsy) and FATIGUE (Experiencing tiredness) in a 23-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, the patient experienced FEELING ABNORMAL (Feeling Heavy), SOMNOLENCE (Feeling very drowsy) and FATIGUE (Experiencing tiredness). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (Feeling Heavy), SOMNOLENCE (Feeling very drowsy) and FATIGUE (Experiencing tiredness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration, Vaccination site erythema, Vaccination site mass, Vaccination site swelling
Clinical narrative: right arm swollen; hard knot; red; second dose on Day 43; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE SWELLING (right arm swollen), VACCINATION SITE MASS (hard knot), VACCINATION SITE ERYTHEMA (red) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on Day 43) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     Concomitant products included PANTOPRAZOLE for GERD, ATORVASTATIN for Hyperlipidemia, GABAPENTIN, AMFETAMINE ASPARTATE, AMFETAMINE SULFATE, DEXAMFETAMINE SACCHARATE, DEXAMFETAMINE SULFATE (ADDERALL), LAMOTRIGINE, CITALOPRAM and LUBIPROSTONE for an unknown indication.   On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Jun-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on Day 43). On 10-Jun-2021, the patient experienced VACCINATION SITE SWELLING (right arm swollen), VACCINATION SITE MASS (hard knot) and VACCINATION SITE ERYTHEMA (red). At the time of the report, VACCINATION SITE SWELLING (right arm swollen), VACCINATION SITE MASS (hard knot), VACCINATION SITE ERYTHEMA (red) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (second dose on Day 43) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   She stated that there is no pain unless it is pressed upon. It looks like a mosquito bite. Her daughter has put a circle around the knot so that they can watch if the knot changes shape or color.  Action taken with mRNA-1273 in response to the event was not applicable.  No treatment medication information were reported
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: 10 people received a dose from an expired vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (10 people received a dose from an expired vaccine) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 021C21A) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced EXPIRED PRODUCT ADMINISTERED (10 people received a dose from an expired vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (10 people received a dose from an expired vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine)  was not applicable.
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Physician stated that the patient did not get the second dose/second dose not scheduled >42 days; This spontaneous case was reported by a physician and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Physician stated that the patient did not get the second dose/second dose not scheduled >42 days) in a 61-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Physician stated that the patient did not get the second dose/second dose not scheduled >42 days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Physician stated that the patient did not get the second dose/second dose not scheduled >42 days) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Treatment information was not provided. Concomitant product use was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: side effects; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION COMPLICATION (side effects) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (side effects). At the time of the report, VACCINATION COMPLICATION (side effects) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: patient past 42 days for second shot; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient past 42 days for second shot) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 15-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient past 42 days for second shot). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (patient past 42 days for second shot) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication was not provided.  Treatment information was not provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Mobility decreased, Myalgia, Pain in extremity
Clinical narrative: the pain with the feet; arm started hurting badly after 3 hours/Consistent stabbing arm pain; Cant lift arm; This spontaneous case was reported by a patient and describes the occurrence of MOBILITY DECREASED (Cant lift arm), PAIN IN EXTREMITY (the pain with the feet) and MYALGIA (arm started hurting badly after 3 hours/Consistent stabbing arm pain) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 054C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jun-2021, the patient experienced MOBILITY DECREASED (Cant lift arm) and MYALGIA (arm started hurting badly after 3 hours/Consistent stabbing arm pain). On an unknown date, the patient experienced PAIN IN EXTREMITY (the pain with the feet). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Pain, at a dose of 1 dosage form. At the time of the report, MOBILITY DECREASED (Cant lift arm), PAIN IN EXTREMITY (the pain with the feet) and MYALGIA (arm started hurting badly after 3 hours/Consistent stabbing arm pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided   Most recent FOLLOW-UP information incorporated above includes: On 11-Jun-2021: No New Information
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Body temperature, Eructation, Fatigue, Feeling abnormal
Clinical narrative: feeling a little off in my stomach; hiccups; burping; vomiting; nausea; muscle aches and pains/ pain all over; pins and needles; tired; fever of 101 point something; brain was messed up; lethargic / couldn't get out of bed; soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pins and needles), ABDOMINAL DISCOMFORT (feeling a little off in my stomach), HICCUPS (hiccups), ERUCTATION (burping) and FEELING ABNORMAL (brain was messed up) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gastritis (Gastrointestinal issues) and Diverticulitis (Gastrointestinal issues).    On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced VACCINATION SITE PAIN (soreness in her arm). On 06-Jun-2021, the patient experienced FEELING ABNORMAL (brain was messed up), LETHARGY (lethargic / couldn't get out of bed), PYREXIA (fever of 101 point something) and FATIGUE (tired). On 07-Jun-2021, the patient experienced PARAESTHESIA (pins and needles) and MYALGIA (muscle aches and pains/ pain all over). On 10-Jun-2021, the patient experienced HICCUPS (hiccups), ERUCTATION (burping), VOMITING (vomiting) and NAUSEA (nausea). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (feeling a little off in my stomach). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency; CEFIXIME (FLEXERIL [CEFIXIME]) at an unspecified dose and frequency; ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form and NAPROXEN at a dose of 1 dosage form. On 05-Jun-2021, VACCINATION SITE PAIN (soreness in her arm) had resolved. On 06-Jun-2021, FEELING ABNORMAL (brain was messed up), LETHARGY (lethargic / couldn't get out of bed), PYREXIA (fever of 101 point something) and FATIGUE (tired) had resolved. At the time of the report, PARAESTHESIA (pins and needles), ABDOMINAL DISCOMFORT (feeling a little off in my stomach), HICCUPS (hiccups), ERUCTATION (burping), VOMITING (vomiting) and NAUSEA (nausea) outcome was unknown and MYALGIA (muscle aches and pains/ pain all over) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jun-2021, Body temperature: 101 (High) Had fever of "101 point something.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient also experienced "up chucking" and a pins and by needles feeling patient deemed the "movie theater experience."   No concomitant medications were reported. The patient reported she saw her HCP for her symptoms.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Hiccups, Lethargy, Myalgia, Nausea, Paraesthesia
Clinical narrative: feeling a little off in my stomach; hiccups; burping; vomiting; nausea; muscle aches and pains/ pain all over; pins and needles; tired; fever of 101 point something; brain was messed up; lethargic / couldn't get out of bed; soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pins and needles), ABDOMINAL DISCOMFORT (feeling a little off in my stomach), HICCUPS (hiccups), ERUCTATION (burping) and FEELING ABNORMAL (brain was messed up) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gastritis (Gastrointestinal issues) and Diverticulitis (Gastrointestinal issues).    On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced VACCINATION SITE PAIN (soreness in her arm). On 06-Jun-2021, the patient experienced FEELING ABNORMAL (brain was messed up), LETHARGY (lethargic / couldn't get out of bed), PYREXIA (fever of 101 point something) and FATIGUE (tired). On 07-Jun-2021, the patient experienced PARAESTHESIA (pins and needles) and MYALGIA (muscle aches and pains/ pain all over). On 10-Jun-2021, the patient experienced HICCUPS (hiccups), ERUCTATION (burping), VOMITING (vomiting) and NAUSEA (nausea). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (feeling a little off in my stomach). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency; CEFIXIME (FLEXERIL [CEFIXIME]) at an unspecified dose and frequency; ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form and NAPROXEN at a dose of 1 dosage form. On 05-Jun-2021, VACCINATION SITE PAIN (soreness in her arm) had resolved. On 06-Jun-2021, FEELING ABNORMAL (brain was messed up), LETHARGY (lethargic / couldn't get out of bed), PYREXIA (fever of 101 point something) and FATIGUE (tired) had resolved. At the time of the report, PARAESTHESIA (pins and needles), ABDOMINAL DISCOMFORT (feeling a little off in my stomach), HICCUPS (hiccups), ERUCTATION (burping), VOMITING (vomiting) and NAUSEA (nausea) outcome was unknown and MYALGIA (muscle aches and pains/ pain all over) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jun-2021, Body temperature: 101 (High) Had fever of "101 point something.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient also experienced "up chucking" and a pins and by needles feeling patient deemed the "movie theater experience."   No concomitant medications were reported. The patient reported she saw her HCP for her symptoms.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Vaccination site pain, Vomiting
Clinical narrative: feeling a little off in my stomach; hiccups; burping; vomiting; nausea; muscle aches and pains/ pain all over; pins and needles; tired; fever of 101 point something; brain was messed up; lethargic / couldn't get out of bed; soreness in her arm; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (pins and needles), ABDOMINAL DISCOMFORT (feeling a little off in my stomach), HICCUPS (hiccups), ERUCTATION (burping) and FEELING ABNORMAL (brain was messed up) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Gastritis (Gastrointestinal issues) and Diverticulitis (Gastrointestinal issues).    On 05-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Jun-2021, the patient experienced VACCINATION SITE PAIN (soreness in her arm). On 06-Jun-2021, the patient experienced FEELING ABNORMAL (brain was messed up), LETHARGY (lethargic / couldn't get out of bed), PYREXIA (fever of 101 point something) and FATIGUE (tired). On 07-Jun-2021, the patient experienced PARAESTHESIA (pins and needles) and MYALGIA (muscle aches and pains/ pain all over). On 10-Jun-2021, the patient experienced HICCUPS (hiccups), ERUCTATION (burping), VOMITING (vomiting) and NAUSEA (nausea). On an unknown date, the patient experienced ABDOMINAL DISCOMFORT (feeling a little off in my stomach). The patient was treated with PARACETAMOL (TYLENOL EXTRA STRENGTH) at an unspecified dose and frequency; CEFIXIME (FLEXERIL [CEFIXIME]) at an unspecified dose and frequency; ASPIRIN [ACETYLSALICYLIC ACID] at a dose of 1 dosage form and NAPROXEN at a dose of 1 dosage form. On 05-Jun-2021, VACCINATION SITE PAIN (soreness in her arm) had resolved. On 06-Jun-2021, FEELING ABNORMAL (brain was messed up), LETHARGY (lethargic / couldn't get out of bed), PYREXIA (fever of 101 point something) and FATIGUE (tired) had resolved. At the time of the report, PARAESTHESIA (pins and needles), ABDOMINAL DISCOMFORT (feeling a little off in my stomach), HICCUPS (hiccups), ERUCTATION (burping), VOMITING (vomiting) and NAUSEA (nausea) outcome was unknown and MYALGIA (muscle aches and pains/ pain all over) was resolving.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 06-Jun-2021, Body temperature: 101 (High) Had fever of "101 point something.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Patient also experienced "up chucking" and a pins and by needles feeling patient deemed the "movie theater experience."   No concomitant medications were reported. The patient reported she saw her HCP for her symptoms.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Pyrexia
Clinical narrative: Fever; Sore arm; fatigue; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever), MYALGIA (Sore arm), FATIGUE (fatigue) and HEADACHE (Headache) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 022B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included High cholesterol medication, High blood pressure medication, Medication for digestion and PAROXETINE for an unknown indication.    On 08-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 08-Jun-2021, the patient experienced PYREXIA (Fever), MYALGIA (Sore arm), FATIGUE (fatigue) and HEADACHE (Headache). On 10-Jun-2021, PYREXIA (Fever), MYALGIA (Sore arm), FATIGUE (fatigue) and HEADACHE (Headache) had resolved.
Sex: U
Vaccine: COVID19
Symptoms: Cough
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of cough in a patient, of an unknown age and gender, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received a dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced cough. At the time of the report, cough outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. No concomitant medication or treatment information provided.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Dry mouth, Headache, Influenza like illness, Pyrexia, Therapeutic response unexpected
Clinical narrative: Unexpected beneficial therapeutic response; flu like symtoms; frequent thirst; dry mouth from Lupus; Headache; felt feverish; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Unexpected beneficial therapeutic response), INFLUENZA LIKE ILLNESS (flu like symtoms), THIRST (frequent thirst), DRY MOUTH (dry mouth from Lupus) and HEADACHE (Headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Lupus erythematosus and Fibromyalgia.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Unexpected beneficial therapeutic response), INFLUENZA LIKE ILLNESS (flu like symtoms), THIRST (frequent thirst), DRY MOUTH (dry mouth from Lupus), HEADACHE (Headache) and PYREXIA (felt feverish). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Unexpected beneficial therapeutic response), INFLUENZA LIKE ILLNESS (flu like symtoms), THIRST (frequent thirst), DRY MOUTH (dry mouth from Lupus), HEADACHE (Headache) and PYREXIA (felt feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient experienced her skin is soft and soaky after receiving the vaccine. She also reported that her skin cleared up from the goosebumps  No concomitant medication reported. Ice packs used as treatment   This case was linked to MOD-2021-216514 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Additional information added include medical history and new events.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Thirst
Clinical narrative: Unexpected beneficial therapeutic response; flu like symtoms; frequent thirst; dry mouth from Lupus; Headache; felt feverish; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Unexpected beneficial therapeutic response), INFLUENZA LIKE ILLNESS (flu like symtoms), THIRST (frequent thirst), DRY MOUTH (dry mouth from Lupus) and HEADACHE (Headache) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Lupus erythematosus and Fibromyalgia.    In March 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Unexpected beneficial therapeutic response), INFLUENZA LIKE ILLNESS (flu like symtoms), THIRST (frequent thirst), DRY MOUTH (dry mouth from Lupus), HEADACHE (Headache) and PYREXIA (felt feverish). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Unexpected beneficial therapeutic response), INFLUENZA LIKE ILLNESS (flu like symtoms), THIRST (frequent thirst), DRY MOUTH (dry mouth from Lupus), HEADACHE (Headache) and PYREXIA (felt feverish) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient experienced her skin is soft and soaky after receiving the vaccine. She also reported that her skin cleared up from the goosebumps  No concomitant medication reported. Ice packs used as treatment   This case was linked to MOD-2021-216514 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Additional information added include medical history and new events.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Second dose not received for >35days; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Second dose not received for >35days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Second dose not received for >35days). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Second dose not received for >35days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant and treatment information were not provided for mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not any causality assessment.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Feeling abnormal, Headache, Lymphadenopathy, Nervousness
Clinical narrative: nervous about rash; "heart beat rate because of panic"; "foggy brain"; "real dizzy"; rash on the face; headache; swollen lymph node left side; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (nervous about rash), PALPITATIONS ("heart beat rate because of panic"), FEELING ABNORMAL ("foggy brain"), DIZZINESS ("real dizzy") and RASH (rash on the face) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy. Concomitant products included LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN D 12 HOUR) for Allergy.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LYMPHADENOPATHY (swollen lymph node left side). On 07-Jun-2021, the patient experienced NERVOUSNESS (nervous about rash), PALPITATIONS ("heart beat rate because of panic"), FEELING ABNORMAL ("foggy brain"), DIZZINESS ("real dizzy"), RASH (rash on the face) and HEADACHE (headache). The patient was treated with HYDROCORTISONE ACETATE (CORTISONE [HYDROCORTISONE ACETATE]) (topical) for Rash, at an unspecified dose and frequency. On 30-May-2021, LYMPHADENOPATHY (swollen lymph node left side) had resolved. At the time of the report, NERVOUSNESS (nervous about rash), PALPITATIONS ("heart beat rate because of panic"), FEELING ABNORMAL ("foggy brain"), DIZZINESS ("real dizzy"), RASH (rash on the face) and HEADACHE (headache) outcome was unknown.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Palpitations, Rash
Clinical narrative: nervous about rash; "heart beat rate because of panic"; "foggy brain"; "real dizzy"; rash on the face; headache; swollen lymph node left side; This spontaneous case was reported by a consumer and describes the occurrence of NERVOUSNESS (nervous about rash), PALPITATIONS ("heart beat rate because of panic"), FEELING ABNORMAL ("foggy brain"), DIZZINESS ("real dizzy") and RASH (rash on the face) in a 46-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 044B21A and 022B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Allergy. Concomitant products included LORATADINE, PSEUDOEPHEDRINE SULFATE (CLARITIN D 12 HOUR) for Allergy.   On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced LYMPHADENOPATHY (swollen lymph node left side). On 07-Jun-2021, the patient experienced NERVOUSNESS (nervous about rash), PALPITATIONS ("heart beat rate because of panic"), FEELING ABNORMAL ("foggy brain"), DIZZINESS ("real dizzy"), RASH (rash on the face) and HEADACHE (headache). The patient was treated with HYDROCORTISONE ACETATE (CORTISONE [HYDROCORTISONE ACETATE]) (topical) for Rash, at an unspecified dose and frequency. On 30-May-2021, LYMPHADENOPATHY (swollen lymph node left side) had resolved. At the time of the report, NERVOUSNESS (nervous about rash), PALPITATIONS ("heart beat rate because of panic"), FEELING ABNORMAL ("foggy brain"), DIZZINESS ("real dizzy"), RASH (rash on the face) and HEADACHE (headache) outcome was unknown.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Back pain, Chest discomfort, Dizziness, Headache, Nausea
Clinical narrative: pain in arm of injection; dizzy; nausea; headache; tingling down arm into fingers; back pain; fever; pressure on chest; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (pain in arm of injection), DIZZINESS (dizzy), NAUSEA (nausea  ), HEADACHE (headache  ) and PARAESTHESIA (tingling down arm into fingers) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 09-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced DIZZINESS (dizzy), NAUSEA (nausea  ), HEADACHE (headache  ), BACK PAIN (back pain  ), PYREXIA (fever   ) and CHEST DISCOMFORT (pressure on chest). On an unknown date, the patient experienced VACCINATION SITE PAIN (pain in arm of injection) and PARAESTHESIA (tingling down arm into fingers). At the time of the report, VACCINATION SITE PAIN (pain in arm of injection), DIZZINESS (dizzy), NAUSEA (nausea  ), HEADACHE (headache  ), PARAESTHESIA (tingling down arm into fingers), BACK PAIN (back pain  ), PYREXIA (fever   ) and CHEST DISCOMFORT (pressure on chest) outcome was unknown.            No relevant concomitant medications were reported.  No treatment information was provided.   This case was linked to MOD-2021-216505, MOD-2021-216360 (Patient Link).